Intron Life Sciences Pvt. Ltd

Premium
InvAscent looks to log another exit from pharma portfolio

Healthcare

14 April, 2025

InvAscent looks to log another exit from pharma portfolio

Healthcare-focused private equity firm InvAscent is looking to exit its more than six-year-old investment in an animal ......

Premium

Healthcare

31 January, 2019

InvAscent's third fund strikes two more deals; hits final close

Healthcare private equity firm InvAscent has struck two new deals from its third fund that just marked its final close, ......